Lipid lowering drugs and recurrences of life-threatening ventricular arrhythmias in high-risk patients
- 28 August 2000
- journal article
- clinical trial
- Published by Elsevier in Journal of the American College of Cardiology
- Vol. 36 (3) , 766-772
- https://doi.org/10.1016/s0735-1097(00)00787-7
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- QT dispersion is not related to infarct size or inducibility in patients with coronary artery disease and life threatening ventricular arrhythmiasHeart, 1999
- Electrical storm in patients with transvenous implantable cardioverter-defibrillatorsJournal of the American College of Cardiology, 1998
- Prevention of Cardiovascular Events and Death with Pravastatin in Patients with Coronary Heart Disease and a Broad Range of Initial Cholesterol LevelsNew England Journal of Medicine, 1998
- Antiatherothrombotic Properties of StatinsJAMA, 1998
- Coronary Risk Factors and Plaque Morphology in Men with Coronary Disease Who Died SuddenlyNew England Journal of Medicine, 1997
- Hyperlipidemia and Coronary DiseaseCirculation, 1995
- Clinical Factors and Angiographic Features Associated With Premature Coronary Artery DiseaseChest, 1995
- Beneficial Effects of Cholesterol-Lowering Therapy on the Coronary Endothelium in Patients with Coronary Artery DiseaseNew England Journal of Medicine, 1995
- Clinical spectrum of ventricular tachycardia.Circulation, 1990
- Clinical characteristics and long-term follow-up in 119 survivors of cardiac arrest: Relation to inducibility at electrophysiologic testingThe American Journal of Cardiology, 1983